XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.3
Subsequent Event
9 Months Ended
Sep. 30, 2025
Subsequent Events [Abstract]  
Subsequent Event Subsequent Event
On November 6, 2025, the Company sold to TPC Investments Royalty LLC, a Delaware limited liability company managed by Oberland Capital Management, LLC ("Oberland"), its interest in Curis Royalty LLC, a wholly owned subsidiary. The sale includes the Erivedge intellectual property, other assets associated with Erivedge and the collaboration agreement with Genentech, in exchange for upfront consideration of $2.5 million and a release of the Company’s liability related to sale of future royalties to Oberland. As a result of executing the sale of the wholly owned subsidiary to Oberland, in the fourth quarter of 2025, the Company will recognize a gain within its statement of operations and comprehensive loss and the liability related to sale of future royalties will be extinguished. Following the sale, the Company will no longer be entitled to revenues under the collaboration agreement with Genentech.